M&A Deal Summary

Calibre Scientific Acquires NeXtal Biotechnologies

On January 8, 2020, Calibre Scientific acquired life science company NeXtal Biotechnologies from Qiagen N.V

Acquisition Highlights
  • This is Calibre Scientific’s 3rd transaction in the Life Science sector.
  • This is Calibre Scientific’s 4th transaction in the United States.
  • This is Calibre Scientific’s 2nd transaction in Ohio.

M&A Deal Summary
Date 2020-01-08
Target NeXtal Biotechnologies
Sector Life Science
Buyer(s) Calibre Scientific
Sellers(s) Qiagen N.V
Deal Type Divestiture

Target

NeXtal Biotechnologies

Holland, Ohio, United States
NeXtal Biotechnologies specializes in the production of unique screens and plates for protein crystallization, an important step in the complex process of structural biology studies and structure-based drug design. NeXtal Biotechnologies is based in Holland, Ohio.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Calibre Scientific

Holland, Ohio, United States
Category Company
Sector Life Science
DESCRIPTION

Calibre Scientific represents a portfolio of niche life science companies, across various key verticals, that have an unrivaled ability to address the unique challenges of their respective markets. Calibre Scientific is based in Holland, Ohio.

DEAL STATS #
Overall 5 of 35
Sector (Life Science) 3 of 7
Type (Divestiture) 2 of 2
State (Ohio) 2 of 2
Country (United States) 4 of 8
Year (2020) 1 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-05-14 BIOZOL Diagnostica Vertrieb

Eching, Germany

BIOZOL Diagnostica Vertrieb is an independent distributor of life science products across Germany. BIOZOL Diagnostica Vertrieb is based in Eching, Germany.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-25 AIT France

Paris, France

AIT France is a manufacturer and distributor of innovative consumables for analytical chemistry and chromatography. The company manufactures proprietary components and distributes a large range of consumables for chromatography and analytical chemistry, including exclusive distribution of products from numerous top brands. AIT France is based in Paris, France.

Buy -

Seller(S) 1

SELLER

Qiagen N.V

Venlo, Netherlands
Category Company
Founded 1984
Sector Life Science
Employees5,200
Revenue 1.5B USD (2019)
DESCRIPTION

QIAGEN N.V. is a Netherlands holding company publically traded on NASDAQ and Frankfurt Prime Standard. The Company is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular insights. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are then used to make these isolated biomolecules visible and ready for interpretation. QIAGEN markets more than 500 products around the world, selling both consumable kits and automation systems to customers through four customer classes: Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Qiagen was founded in 1986 and is based in Venlo, the Netherlands.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Ohio) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-01-07 N-of-One

Concord, Massachusetts, United States

N-of-One, Inc. is a provider in clinical interpretation of molecular tests in oncology. N-of-One solutions can standardize and accelerate genomic clinical interpretation and molecular decision support while saving time and money. N-of-One, Inc. was founded in 2008 and is based in Concord, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-17 NeuMoDx Molecular

Ann Arbor, Michigan, United States

NeuMoDx Molecular, Inc. designs and develops revolutionary molecular diagnostic solutions for hospital and clinical reference laboratories. NeuMoDx Molecular was founded in 2012 and is based in Ann Arbor, Michigan.

Buy $248M
Mergr

Product

Company

Legal